<VariationArchive VariationID="1076502" VariationName="NM_001164277.2(SLC37A4):c.925del (p.Ala309fs)" VariationType="Deletion" Accession="VCV001076502" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-04-15" DateCreated="2021-05-10" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1062249" VariationID="1076502">
      <GeneList>
        <Gene Symbol="SLC37A4" FullName="solute carrier family 37 member 4" GeneID="2542" HGNC_ID="HGNC:4061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119024112" stop="119030877" display_start="119024112" display_stop="119030877" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_009646203.1" start="45712" stop="52476" display_start="45712" display_stop="52476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118895060" stop="118901615" display_start="118895060" display_stop="118901615" Strand="-" />
          </Location>
          <OMIM>602671</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164277.2(SLC37A4):c.925del (p.Ala309fs)</Name>
      <CanonicalSPDI>NC_000011.10:119026025:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119026026" stop="119026026" display_start="119026026" display_stop="119026026" variantLength="1" positionVCF="119026025" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118896736" stop="118896736" display_start="118896736" display_stop="118896736" variantLength="1" positionVCF="118896735" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A236fs</ProteinChange>
      <ProteinChange>A309fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_187" sequenceAccession="LRG_187">
            <Expression>LRG_187:g.9880del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_187t1" sequenceAccession="LRG_187t1">
            <Expression>LRG_187t1:c.925del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119026027del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119026027del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118896737del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118896737del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013331.1" sequenceAccession="NG_013331" sequenceVersion="1" change="g.9880del">
            <Expression>NG_013331.1:g.9880del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164277.2" sequenceAccession="NM_001164277" sequenceVersion="2" change="c.925del" MANESelect="true">
            <Expression>NM_001164277.2:c.925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157749.1" sequenceAccession="NP_001157749" sequenceVersion="1" change="p.Ala309fs">
            <Expression>NP_001157749.1:p.Ala309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164278.2" sequenceAccession="NM_001164278" sequenceVersion="2" change="c.925del">
            <Expression>NM_001164278.2:c.925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157750.1" sequenceAccession="NP_001157750" sequenceVersion="1" change="p.Ala309fs">
            <Expression>NP_001157750.1:p.Ala309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164279.2" sequenceAccession="NM_001164279" sequenceVersion="2" change="c.706del">
            <Expression>NM_001164279.2:c.706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157751.1" sequenceAccession="NP_001157751" sequenceVersion="1" change="p.Ala236fs">
            <Expression>NP_001157751.1:p.Ala236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164280.2" sequenceAccession="NM_001164280" sequenceVersion="2" change="c.925del">
            <Expression>NM_001164280.2:c.925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157752.1" sequenceAccession="NP_001157752" sequenceVersion="1" change="p.Ala309fs">
            <Expression>NP_001157752.1:p.Ala309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001467.6" sequenceAccession="NM_001467" sequenceVersion="6" change="c.925del">
            <Expression>NM_001467.6:c.925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001458.1" sequenceAccession="NP_001458" sequenceVersion="1" change="p.Ala309fs">
            <Expression>NP_001458.1:p.Ala309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2134631619" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164277.2(SLC37A4):c.925del (p.Ala309fs) AND Glucose-6-phosphate transport defect" Accession="RCV001390446" Version="8">
        <ClassifiedConditionList TraitSetID="1910">
          <ClassifiedCondition DB="MedGen" ID="C0268146">Glucose-6-phosphate transport defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-30" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-30" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10940311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9758626</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9781688</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1910" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5201" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 1B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glucose-6-phosphate transport defect</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+1B/3121" DB="Genetic Alliance" />
                <XRef ID="30102006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD Ib</ElementValue>
                <XRef Type="MIM" ID="232220" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD1B</ElementValue>
                <XRef Type="MIM" ID="232220" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type I (GSDI) is characterized by accumulation of glycogen and fat in the liver and kidneys resulting in hepatomegaly and nephromegaly. Severely affected infants present in the neonatal period with severe hypoglycemia due to fasting intolerance. More commonly, untreated infants present at age three to four months with hepatomegaly, severe hypoglycemia with or without seizures, lactic acidosis, hyperuricemia, and hypertriglyceridemia. Affected children typically have doll-like faces with full cheeks, relatively thin extremities, short stature, and a protuberant abdomen. Xanthoma and diarrhea may be present. Impaired platelet function and development of reduced or dysfunctional von Willebrand factor can lead to a bleeding tendency with frequent epistaxis and menorrhagia in females. Individuals with untreated GSDIb are more likely to develop impaired neutrophil and monocyte function as well as chronic neutropenia resulting in recurrent bacterial infections, gingivitis, periodontitis, and genital and intestinal ulcers. Long-term complications of untreated GSDI include short stature, osteoporosis, delayed puberty, renal disease (including proximal and distal renal tubular acidosis, renal stones, and renal failure), gout, systemic hypertension, pulmonary hypertension, hepatic adenomas with potential for malignancy, pancreatitis, and polycystic ovaries. Seizures and cognitive impairment may occur in individuals with prolonged periods of hypoglycemia. Normal growth and puberty are expected in treated children. Most affected individuals live into adulthood.</Attribute>
                <XRef ID="NBK1312" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301489</ID>
                <ID Source="BookShelf">NBK1312</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">25356975</ID>
              </Citation>
              <XRef ID="364" DB="Orphanet" />
              <XRef ID="79259" DB="Orphanet" />
              <XRef ID="C0268146" DB="MedGen" />
              <XRef ID="MONDO:0009288" DB="MONDO" />
              <XRef Type="MIM" ID="232220" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4021378" SubmissionDate="2022-01-06" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="NM_001164277.1:c.925delG|MedGen:C0268146" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002051341" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9781688</ID>
          </Citation>
          <Comment>Variant summary: SLC37A4 c.925delG (p.Ala309LeufsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 239730 control chromosomes. c.925delG has been reported in the literature in individuals affected with Glycogen Storage Disease Type Ib (Marcolongo_1998). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC37A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001164277.1:c.925delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268146" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10903261</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7851054" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001164277.2:c.925del|OMIM:232220" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004202473" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001164277.2:c.925del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232220" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3117870" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="5889060|MedGen:C0268146" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001592185" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9758626</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10940311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9781688</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala309Leufs*3) in the SLC37A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC37A4 are known to be pathogenic (PMID: 9758626, 10940311). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1076502). This variant is also known as 1094delG. This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 9781688). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC37A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.118896736del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268146" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7851054" TraitType="Disease" MappingType="XRef" MappingValue="232220" MappingRef="OMIM">
        <MedGen CUI="C0268146" Name="Glucose-6-phosphate transport defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4021378" TraitType="Disease" MappingType="XRef" MappingValue="C0268146" MappingRef="MedGen">
        <MedGen CUI="C0268146" Name="Glucose-6-phosphate transport defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3117870" TraitType="Disease" MappingType="XRef" MappingValue="C0268146" MappingRef="MedGen">
        <MedGen CUI="C0268146" Name="Glucose-6-phosphate transport defect" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

